Meridiem Capital Partners LP Purchases Shares of 561,427 Avantor, Inc. (NYSE:AVTR)

Meridiem Capital Partners LP purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 561,427 shares of the company's stock, valued at approximately $11,829,000. Meridiem Capital Partners LP owned about 0.08% of Avantor at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Perpetual Ltd lifted its position in Avantor by 38.7% in the 4th quarter. Perpetual Ltd now owns 1,766,882 shares of the company's stock worth $37,228,000 after buying an additional 493,408 shares during the last quarter. Rhumbline Advisers lifted its position in Avantor by 1.8% in the 4th quarter. Rhumbline Advisers now owns 1,922,368 shares of the company's stock worth $40,504,000 after buying an additional 33,692 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Avantor by 2.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,027,636 shares of the company's stock worth $63,792,000 after buying an additional 74,735 shares during the last quarter. Blue Trust Inc. lifted its position in Avantor by 6.9% in the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock worth $170,000 after buying an additional 522 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its position in Avantor by 38.1% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 119,063 shares of the company's stock worth $2,509,000 after buying an additional 32,838 shares during the last quarter. Institutional investors own 95.08% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Citigroup reduced their target price on Avantor from $22.00 to $18.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Royal Bank of Canada reduced their target price on Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Wells Fargo & Company reduced their target price on Avantor from $25.00 to $22.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. TD Cowen cut Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price on the stock. in a research note on Monday, April 28th. Finally, The Goldman Sachs Group cut Avantor from a "buy" rating to a "neutral" rating and reduced their target price for the company from $23.00 to $14.00 in a research note on Tuesday, April 29th. Seven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, Avantor presently has an average rating of "Hold" and a consensus price target of $18.88.

Avantor Stock Up 4.3%

Avantor stock traded up $0.56 during mid-day trading on Friday, hitting $13.40. The company had a trading volume of 22,017,022 shares, compared to its average volume of 7,794,817. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The stock's 50 day moving average price is $14.76 and its two-hundred day moving average price is $18.59. Avantor, Inc. has a 12 month low of $11.82 and a 12 month high of $28.00. The company has a market capitalization of $9.13 billion, a PE ratio of 12.88, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09.

Avantor (NYSE:AVTR - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting the consensus estimate of $0.23. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the previous year, the company posted $0.22 earnings per share. The company's revenue for the quarter was down 5.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Gregory L. Summe acquired 25,000 shares of Avantor stock in a transaction that occurred on Wednesday, May 7th. The stock was bought at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the completion of the transaction, the director now owns 50,000 shares in the company, valued at $600,000. The trade was a 100.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph R. Massaro acquired 8,100 shares of Avantor stock in a transaction that occurred on Tuesday, April 29th. The shares were purchased at an average price of $12.30 per share, with a total value of $99,630.00. Following the transaction, the director now owns 35,038 shares of the company's stock, valued at $430,967.40. The trade was a 30.07% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.20% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.